TNS: 'Common currency' can help compare tactics

Share this article:
Having trouble comparing blogs, text messages or word-of-mouth to other forms of communication modes in terms of how they influence your brand?

That's understandable, given the tremendous escalation in communication channels, according to TNS Healthcare. The firm has a new methodology designed to measure the cost effectiveness of an array of media, to help marketers make sound budget allocation decisions.

“There's so many different ways that consumers or physicians can encounter brands,” said David Kweskin, TNS Healthcare SVP and practice area leader. “Through this method, we put them all on the same playing field and come up with a metric—called the ‘brand experience point' [BEP]--which allows us to compare and contrast the different contact points.”

BEPs let clients put measured media--TV, radio, print--and non-measured media side-by-side, TNS said. The metric, dubbed “MarketContactAudit,” tracks up to 35 different contact points, including point-of-care channels.

Determining “cost per BEP,” basically allocating cost to customer contacts, may help achieve marketing accountability, TNS said.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...